SCHEMBL1385018

SCHEMBL1385018

Nc1ncnc2cc(CN3CCN(C(=O)C(=O)Nc4ccc(Cl)s4)CC3=O)ccc12

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.52
MAP4K4 O95819 1/20 0.33
DPP4 P27487 5/20 0.32
AKT1 P31749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1653352 0.92 F10 (0.53) F10MAP4K4DPP4
SCHEMBL1654455 0.85 F10 (0.58) F10MAP4K4
SCHEMBL1651375 0.82 F10 (0.54) F10DPP4
SCHEMBL1385117 0.82 F10 (0.43) F10
SCHEMBL1385120 0.82 F10 (0.43) F10
SCHEMBL1652171 0.82 F10 (0.52) F10
SCHEMBL1387093 0.82 F10 (0.42) F10
SCHEMBL1387090 0.82 F10 (0.42) F10
SCHEMBL1654561 0.81 F10 (0.48) F10MAP4K4DPP4AKT1
SCHEMBL1654563 0.81 F10 (0.48) F10MAP4K4DPP4AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
CN-1420882-A Substd. oxoazaheterocyclyl compounds AVENTIS PHARM PROD INC (US) 2003-05-28 CN claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed
CN-1420882-A Substd. oxoazaheterocyclyl compounds AVENTIS PHARM PROD INC (US) 2003-05-28 CN disclosed